报名：第七届生物制药研发及质量控制网络大会

Core Insights - The global biopharmaceutical industry is entering a rapid development phase, with accelerated technological iterations in cutting-edge fields such as antibody drugs, cell and gene therapy, and radiolabeled drug conjugates (RDC) [1] - Domestic policies are increasingly supporting innovative drug research and the standardization of quality control, presenting new opportunities for industry growth [1] Conference Highlights - Comprehensive coverage of five core biopharmaceutical areas: antibody/protein drugs, cell and gene therapy, nucleic acid drugs, peptide drugs, and RDC, addressing the entire "research and development - quality control" chain [2] - Over 25 top experts from industry and academia will participate, including R&D and quality control directors, renowned professors, and clinical department heads, fostering deep integration of industry, academia, and clinical practice [2] - All presentations will focus on core technologies and practical methods, utilizing real case studies to address technical challenges and solutions, enhancing attendees' ability to apply these methods in their work [2] Conference Details - The conference will take place from March 24 to 26, 2026, organized by the Instrument Information Network, with support from key laboratories and professional committees [4] Agenda Overview - The agenda includes specialized sessions on various topics such as antibody drug conjugation techniques, nucleic acid drug development, and quality control in cell and gene therapy, featuring presentations from leading experts in the field [5][6][7]